Five Alarm Bio, a UK drug discovery startup focussing on the underlying mechanisms of ageing to develop therapeutics for age-related disease, works with Magnitude Biosciences to test their compound, FAB001, to test their hypothesis on the nature of ageing. Related Resources

Contract research organisation Magnitude Biosciences is projecting significant growth as it looks to tap into the multi-billion-pound nutraceutical and pharmaceutical industry, automate workstreams, expand its commercial team and increase its global footprint. The biotech company, which spun out from Durham University and moved to NETPark in 2020, uses tiny nematode worms known as Caenorhabditis elegans […]

Welcome to the fascinating world of C. elegans, a microscopic nematode worm that holds the key to unlocking groundbreaking insights in drug discovery. In this blog series, we embark on a journey into the intricate realm of this tiny organism, renowned for its simplicity and remarkable genetic similarities to humans. Join us as we explore […]

Press Release: 24th July 2023 Photo:  From left to right: Prof Carrie Ambler, (LightOx) Dr Sam Whitehouse (LightOx), Dr Fozia Saleem (Magnitude Biosciences), Chi Onwurah (Labour MP and Shadow Minister for Science Research and Digital), Olusola (Sola) Idowu (Hexis Lab), Dr Andrew Pike (NunaBio) Newcastle based Life Sciences and Biomedical businesses, LightOx, NunaBio, Magnitude Biosciences […]

Photo: The Magnitude Biosciences Team May 2023, Sedgefield, United Kingdom Magnitude Biosciences Limited, a specialist provider of C. elegans research services to the longevity, nutraceuticals, and pharmaceutical industries based in the North East of England, has been awarded a Future Economy Investor Partnerships grant of nearly £250,000 by Innovate UK.  The grant will be matched […]

CSO Dr. David Weinkove talks to Dr. Manish Chamoli, lead C. elegans scientist on the recent taurine longevity study

Magnitude Biosciences partnered with AB Biotek Human Nutrition & Health (ABB HNH), the global leader in yeast probiotics and postbiotics. Recently we had the pleasure of hosting Maria Tintoré and Carlos de Lecea from AB Biotek at our lab in Sedgefield, UK. There is growing evidence on how health problems and diseases are linked to […]

We help our partners in the nutraceuticals & ingredients industry uncover and validate the diverse health benefits of their compounds. These include novel nutraceuticals, branded ingredients and microbiotics that act through the gut microbiome (prebiotics, probiotics and postbiotics - SCFAs). Our world-leading CRO expertise enables you to elucidate the health benefits and mechanism of actions […]

Lundbeck collaborates with Magnitude on innovate platform to test neurodegenerative disease interventions

Magnitude Biosciences Limited, a specialist provider of C. elegans research services to the longevity, nutraceuticals and pharmaceutical industries, has closed a fourth round of investment to accelerate the scaling of its business.